FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367052003> ?p ?o ?g. }

• W4367052003 abstract "Abstract Background Safely inhibiting the formation of scar in the glaucoma filtration surgery (GFS) has always been an issue for clinical glaucoma doctors. Anti-vascular endothelial growth factor (VEGF) agents can reduce angiogenesis, and anti-placental growth factor (PIGF) agents can affect reactive gliosis. However, the effect of conbercept, which can bind to both VEGF and PIGF, on human Tenon’s fibroblasts (HTFs) is unknown. Methods HTFs were cultured in vitro and treated with conbercept or bevacizumab (BVZ). No drug was added to the control group. The effects of drugs on cell proliferation were assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the collagen type I alpha1(Col1A1) mRNA expression level was measured using quantitative polymerase chain reaction (qPCR). HTF cell migration after drug interventions was evaluated using the scratch wound assay along with the measurement of the expression levels of VEGF and PIGF in human umbilical vein endothelial cells (HUVECs) using enzyme-linked immunosorbent assay, as well as the detection of the VEGF(R) mRNA expression level in HTFs using qPCR. Results After the addition of conbercept (0.01, 0.1, and 1 mg/mL) to the cultured HTFs or HUVECs, no significant cytotoxicity was observed compared with the control group, while the cytotoxicity of 2.5 mg/mL BVZ on HTFs was obvious. Conbercept significantly inhibited HTF cell migration and Col1A1 mRNA expression level in HTFs. It was superior to BVZ in inhibiting HTF migration. After the intervention with conbercept, the expression level of PIGF and VEGF in HUVECs significantly decreased; and the inhibitory effect of conbercept on the expression level of VEGF in HUVECs was weaker than that of BVZ. Conbercept was more advantageous than BVZ in inhibiting the expression level of VEGFR-1 mRNA in HTFs. However, its effect in terms of inhibiting the expression level of VEGFR-2 mRNA in HTFs was weaker than that of BVZ. Conclusion The results suggested the low cytotoxicity and significant anti-scarring effect of conbercept in HTF with significant anti-PIGF and inferior anti-VEGF effects compared with BVZ, thus providing a better understanding of the role of conbercept in the GFS wound healing process." @default.
• W4367052003 created "2023-04-27" @default.
• W4367052003 creator A5005551799 @default.
• W4367052003 creator A5006647592 @default.
• W4367052003 creator A5032597656 @default.
• W4367052003 creator A5084138424 @default.
• W4367052003 date "2023-04-26" @default.
• W4367052003 modified "2023-10-01" @default.
• W4367052003 title "Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab" @default.
• W4367052003 cites W1520623323 @default.
• W4367052003 cites W1751196650 @default.
• W4367052003 cites W1875554126 @default.
• W4367052003 cites W1941180110 @default.
• W4367052003 cites W1970526607 @default.
• W4367052003 cites W1974694051 @default.
• W4367052003 cites W1987087672 @default.
• W4367052003 cites W1999788757 @default.
• W4367052003 cites W2000292756 @default.
• W4367052003 cites W2004655576 @default.
• W4367052003 cites W2004845166 @default.
• W4367052003 cites W2006432488 @default.
• W4367052003 cites W2009182854 @default.
• W4367052003 cites W2011003854 @default.
• W4367052003 cites W2021341794 @default.
• W4367052003 cites W2026169552 @default.
• W4367052003 cites W2029089767 @default.
• W4367052003 cites W2037623038 @default.
• W4367052003 cites W2037680183 @default.
• W4367052003 cites W2045344873 @default.
• W4367052003 cites W2045992045 @default.
• W4367052003 cites W2050312213 @default.
• W4367052003 cites W2053051952 @default.
• W4367052003 cites W2060085062 @default.
• W4367052003 cites W2066507973 @default.
• W4367052003 cites W2067236079 @default.
• W4367052003 cites W2072598952 @default.
• W4367052003 cites W2073980565 @default.
• W4367052003 cites W2075678437 @default.
• W4367052003 cites W2083124053 @default.
• W4367052003 cites W2119281341 @default.
• W4367052003 cites W2137029911 @default.
• W4367052003 cites W2138248251 @default.
• W4367052003 cites W2141926986 @default.
• W4367052003 cites W2145310248 @default.
• W4367052003 cites W2156294916 @default.
• W4367052003 cites W2157501021 @default.
• W4367052003 cites W2167351436 @default.
• W4367052003 cites W2318323062 @default.
• W4367052003 cites W2522106976 @default.
• W4367052003 cites W2758894659 @default.
• W4367052003 cites W2890112305 @default.
• W4367052003 cites W2899281139 @default.
• W4367052003 cites W2982241585 @default.
• W4367052003 cites W2992431870 @default.
• W4367052003 cites W44172448 @default.
• W4367052003 doi "https://doi.org/10.1186/s12886-023-02914-4" @default.
• W4367052003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37101202" @default.
• W4367052003 hasPublicationYear "2023" @default.
• W4367052003 type Work @default.
• W4367052003 citedByCount "1" @default.
• W4367052003 countsByYear W43670520032023 @default.
• W4367052003 crossrefType "journal-article" @default.
• W4367052003 hasAuthorship W4367052003A5005551799 @default.
• W4367052003 hasAuthorship W4367052003A5006647592 @default.
• W4367052003 hasAuthorship W4367052003A5032597656 @default.
• W4367052003 hasAuthorship W4367052003A5084138424 @default.
• W4367052003 hasBestOaLocation W43670520031 @default.
• W4367052003 hasConcept C109316439 @default.
• W4367052003 hasConcept C126322002 @default.
• W4367052003 hasConcept C153911025 @default.
• W4367052003 hasConcept C16685009 @default.
• W4367052003 hasConcept C167734588 @default.
• W4367052003 hasConcept C185592680 @default.
• W4367052003 hasConcept C202751555 @default.
• W4367052003 hasConcept C2776694085 @default.
• W4367052003 hasConcept C2777025900 @default.
• W4367052003 hasConcept C2777411675 @default.
• W4367052003 hasConcept C2777802072 @default.
• W4367052003 hasConcept C2780394083 @default.
• W4367052003 hasConcept C502942594 @default.
• W4367052003 hasConcept C55493867 @default.
• W4367052003 hasConcept C71924100 @default.
• W4367052003 hasConcept C86803240 @default.
• W4367052003 hasConcept C98274493 @default.
• W4367052003 hasConceptScore W4367052003C109316439 @default.
• W4367052003 hasConceptScore W4367052003C126322002 @default.
• W4367052003 hasConceptScore W4367052003C153911025 @default.
• W4367052003 hasConceptScore W4367052003C16685009 @default.
• W4367052003 hasConceptScore W4367052003C167734588 @default.
• W4367052003 hasConceptScore W4367052003C185592680 @default.
• W4367052003 hasConceptScore W4367052003C202751555 @default.
• W4367052003 hasConceptScore W4367052003C2776694085 @default.
• W4367052003 hasConceptScore W4367052003C2777025900 @default.
• W4367052003 hasConceptScore W4367052003C2777411675 @default.
• W4367052003 hasConceptScore W4367052003C2777802072 @default.
• W4367052003 hasConceptScore W4367052003C2780394083 @default.
• W4367052003 hasConceptScore W4367052003C502942594 @default.
• W4367052003 hasConceptScore W4367052003C55493867 @default.
• W4367052003 hasConceptScore W4367052003C71924100 @default.
• W4367052003 hasConceptScore W4367052003C86803240 @default.

• next